A team from UNIGE and HUG has discovered a subgroup of immune cells particularly involved in the disease, opening the way to ...

Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

“Identifying the causes and risk factors of MS and substantiating the effectiveness of certain interventions are both crucial ...

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Advances being used to treat cancer are now being applied to lupus, rheumatoid arthritis, and other disorders.

Roche has reported wins for its BTK inhibitor fenebrutinib in a pair of phase 3 studies across two multiple sclerosis (MS) populations. One victory was based on the finding that the candidate was ...

Explore how the Veteran Affairs (VA) MS Centers of Excellence enhance veteran care through a hub-and-spoke model, telehealth, and groundbreaking research.

Fox News host and meteorologist Janice Dean said she is taking a break from work to be with her family amid "health issues." ...